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SBackground: Nd:YAG laser (1064 nm) is standard in bronchology. The thulium fiber laser (1940 nm) has a
nearly 1000-fold increased absorption in water, enabling precise tissue ablation with a small margin of
coagulation, whereas 1064-nm laser light penetrates deeper into tissue with less controllable effects.
Objectives: To assess the safety, feasibility, and versatility of endobronchial thulium laser therapy in an
observational cohort study.
Methods: Endobronchial treatment with the thulium fiber laser was performed in a cohort study of 187
bronchoscopies on 132 consecutive patients with 135 endobronchial lesions amenable to laser resection.
Results: The thulium fiber laser produced superficial, precise, and rapid tissue ablation. Eighty-one lesions were
completely vaporized; 82 lesions were treated by deep tissue destruction by inserting the fiber into tissue
followed by mechanical resection. Tumor bleeding was coagulated with rapid and sustained hemostasis
(n ¼ 28). Nitinol stents were removed after resection of severe granulation tissue overgrowth (n ¼ 10).
Intact stents were maintained after ablation of in-stent tissue (n ¼ 47). In 11 cases, bleeding occurred during
laser treatment (n ¼ 11 of 187). Power settings between 5 and 20 W were found to be safe.
Conclusions: Endobronchial therapy with the thulium laser at 1940 nm seems to be safe, feasible, and highly
versatile for treatment of airway stenosis and stent obstruction caused by tissue ingrowth. Further studies are
warranted. (J Thorac Cardiovasc Surg 2014;147:1827-32)Video clip is available online.
The Nd:YAG laser emitting at a wavelength of 1064 nm has
been used in interventional bronchoscopy for decades.1,2
The principles of its use have been described by Dumon
and colleagues.3 The efficacy of this wavelength for
endobronchial application via flexible devices has been
explored in large case series.4,5
The interaction between light and tissue depends on the
wavelength of the light and the optical parameters of the
tissue. The optical penetration depth as well as the resulting
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The Journal of Thoracic and CarNd:YAG laser beam travels deeply into pale tissue, whereas
dark tissue colors (eg, blood or charring) result in high
absorption and limited penetration. The extent of deep
laser-induced damage within the target tissue is difficult
to predict. Laser energy deposition can increase the temper-
ature in deeper layers of the tissue to higher than the boiling
point of water. Rapidly expanding pockets of steam can
explode and erupt through the tissue surface (popcorn
effect), obscuring the operating field and causing tissue
perforation and hemorrhage.
The diode pumped thulium fiber laser (TmFL) emits light
at a wavelength of 1940 nm in continuous mode. This
wavelength coincides with a local maximum in the
absorption spectrum of water7-9 (Figure 1), leading to a
nearly 1000-fold increased absorption coefficient in water
comparedwith the 1064 nmwavelength.10Although for light
at 1064 nm, water and other tissue chromophores are
potential absorbers, light at 1940 nm is mainly absorbed by
tissue water and therefore has a specific target. Because of
its high absorption, the optical penetration depth into tissue
is low and the energy is mainly absorbed near the tissue
surface, enabling precise and predictable tissue ablation.
Clinically, the thulium laserwavelengthwasfirst introduced
in urology for prostate resection,11-14 and is currently under
study for in laparoscopic partial nephrectomy,10,15-17 It has
also been used in otorhinolaryngology,18-21 ophthal-
mology,22,23 and neurology.24,25 These studies characterize
the device as a precise cutting tool with well-defined thermal
damage ensuring hemostasis.diovascular Surgery c Volume 147, Number 6 1827
Abbreviation and Acronym
TmFL ¼ thulium fiber laser
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SConsidering its physical properties and the experience in
other medical specialties, it was hypothesized that the use of
thulium laser light in bronchoscopy would improve clinical
laser application with respect to some side effects induced
by the gold standard Nd:YAG laser. To show safety and
feasibility and to explore the clinical potential of this
new wavelength, an observational cohort study was
performed, reporting the first experience using a TmFL in
interventional pulmonology.MATERIALS AND METHODS
In a referral center for interventional pulmonology
(Asklepios-Fachkliniken Munich-Gauting, Germany) from September
2011 to January 2013, consecutive patients with endobronchial lesions
amenable to laser-assisted tissue resection26 were treated with the TmFL.
Patients gave written informed consent before the intervention. The study
was approved by the Ethical Committee of Ludwig-Maximilians-
University of Munich (project no. 410/10).
Procedures were performed using rigid bronchoscopy under
general anesthesia and jet ventilation as described elsewhere.1 During
bronchoscopy, the type of endobronchial lesion (exophytic tissue, extrinsic
compression, or stricture) and degree of airway stenosis before and after the
procedure (no stenosis, lumen reduction 25%, 26%-50%, 51%-75%,
76%-90%, or 91%-100%) were assessed according to a recently proposed
classification.27 During laser light application, the fraction of inspired
oxygen (FiO2) was reduced to less than 40%.
Laser treatment was performed using a TmFL (Vela, StarMedTec, Starn-
berg,Germany)emitting at1940nmincontinuousmode.Thepoweremission
was set from5 to 50Wat increments of 1W. The light energywas transported
via a flexible quartz bare fiber (core diameter 365mm) introduced through the
working channel of a flexible videobronchoscope (BF-1T180, Olympus,
Hamburg, Germany; Figure 2). Initially, the power setting was restricted
to 5W. During the early case series, laser power was titrated upward in incre-
ments of 5Waccording to the observed effect and risk; the most intuitive risk
of high energy levels is laser-induced fire, because interventional bronchos-
copy works in an oxygen-rich environment. Other endobronchial treatments
were applied as needed.
Individual patients with endobronchial lesions amenable for laser
intervention by bronchoscopy were recorded. Every bronchoscopy with
endobronchial laser application was evaluated as a separate case.
TmFL procedure-related adverse events were documented; for example,
bleeding, popcorn effect, perforation of airway wall, laser-induced fire
defined as persistent burning of carbonized tissue, laser fiber, or the flexible
bronchoscope.
As the focus of the study was on feasibility and short-term effects, there
was no formal follow-up of the patient cohort. Follow-up bronchoscopies
were only performed as indicated by the clinical course of the patients
during the study period.
Data are shown as means  standard deviation.RESULTS
Patient Cohort and Lesions
One hundred thirty-two patients (mean age 64.5  12.1
years; range, 22-88 years; 82 male, 50 female) underwent1828 The Journal of Thoracic and Cardiovascular Sur187 bronchoscopies with laser application (1 bronchoscopy,
n ¼ 103, 2 bronchoscopies, n ¼ 14; 3 bronchoscopies,
n ¼ 10, 4 bronchoscopies, n ¼ 2; and 5, 6, and 7
bronchoscopies, each n ¼ 1). The 55 repeat laser
bronchoscopies were performed because of insufficient
effect of the first bronchoscopy (n ¼ 6; Dt ¼ 4.8  2.9
days; range, 1-10 days) or recurrence of the endobronchial
lesion (n¼ 49;Dt¼ 174.9 146.4 days; range, 11-636days).
One hundred thirty-five different endobronchial lesions
were treated; 97 (71.9%) were malignant and 38 (28.1%)
benign. Diagnoses are shown in Table 1.
The type of airway stenosis was judged to be exophytic in
73 (39%) cases, a combination of exophytic tissue and
extrinsic compression in 82 (44%) cases, and a benign
stricture in 30 (16%) cases. In an additional 2 cases without
stenosis, laser light application was used for hemostasis
(1%).
In exophytic and combination stenosis, the exophytic
part of the lesion was regarded as polypoid in 35 (22.6%)
cases and broad based in 120 (77.4%) cases. The
localization of the treated lesions is shown in Table 2.
Procedure
The mean procedure time was 44.6  29.4 minutes
(range, 12-200 minutes), mean laser-on time was 6.3 
7.1 minutes (range, 1-41 minutes). The initial power setting
of 5W induced tissue ablation but the hemostatic effect was
not sufficient in all cases. The laser output power could
safely be increased up to 20 W. At power values larger
than 20 W, progressive emission of sparks from the treated
tissue was observed. Suspecting an increased risk of laser
fire, the use of these high-power settings was avoided.
The optimal power setting was found to be 10 W with a
sufficient combination of ablative and hemostatic effects.
With endobronchial treatment using the TmFL,
superficial, rapid, and precise tissue ablation began immedi-
ately on activation of the laser at the lowest possible power
setting of 5 W. Vaporization of tissue produced smoke,
which was easily removed by suction through the flexible
bronchoscope. Otherwise the operating field stayed clean
during the procedure.
Frequently, TmFL resection was combined with other
endobronchial treatment modalities (n ¼ 104), such as
stenting (n ¼ 52) of residual compression stenosis after
laser resection of exophytic tissue, dilation (n ¼ 23),
cryorecanalization (n ¼ 20) for the extraction of large
exophytic tumors,28 tamponade with swabs (n ¼ 5), argon
plasma coagulation (n¼ 2) for hemostasis in large bleeding
surface areas, and resection with the electrosurgical snare
(n ¼ 2) for the removal of pedunculated lesions.
In cases of early follow-up bronchoscopy, the laser-
treated area showed a thin layer of fibrin deposit and
necrosis. Debridement was not required at the site of the
previous intervention in any patient.gery c June 2014
FIGURE 1. Absorption coefficient of water7-9 and position of the thulium
fiber laser (1940 nm) and the Nd:YAG laser (1064 nm).
TABLE 1. Diagnosis for 135 lesions treated with endobronchial
thulium fiber laser light application and corresponding type
Diagnosis n
Type of lesion (n)*
Exophytic Mixed Stricture
Malignant disease (n ¼ 97)
Non–small cell lung cancer 48 16 32
Small cell lung cancer 11 3 8
Endobronchial metastasis 26 12 14
Renal cell carcinoma 7 3 4
Esophageal carcinoma 5 2 3
Sarcoma 4 3 1
Colonic carcinoma 3 1 2
Thyroid carcinoma 3 2 1
Anal carcinoma 1 1
Endometrium carcinoma 1 1
Laryngeal carcinoma 1 1
Penile carcinoma 1 1
Low grade malignancies 12 9 3
Typical carcinoid 7 7
Adenoid cystic carcinoma 4 1 3
Mucoepidermoid carcinoma 1 1
Benign disease (n ¼ 38)
Granulation tissue 21 16 3 2
Due to a stent 17 12 3 2
Due to a tracheotomy tube 4 4
Scar stricture 7 7
Subglottic stenosis in Wegener
disease
3 3
Post-tracheotomy stenosis 3 3
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Before laser treatment, significant airway stenosis
defined as a degree of stenosis of 50% or more was
diagnosed in 145 cases. Immediate reconstitution of a
patent airway (<50% stenosis) was possible in 123 cases
(85%) as shown in Figure 3. Recanalization failed because
of complex pathology with exophytic tissue and extrinsic
compression and multilocular involvement down to the
segmental level in the remaining 22 patients.Stenotic anastomosis after lung
transplantation
2 1 1
Lipoma 1 1
Bleeding after biopsy 1
*Mixed, a combination of exophytic tissue þ extrinsic compression; pure extrinsic
compression is not part of this study as lesions of this type are not amenable to laser
resection.
TABLE 2. Location of treated endobronchial lesions in 187 cases (52%
of cases showed complex lesions involving more than 1 site giving aEffects With Respect to Type of Lesion
Eighty-one small exophytic lesions in 65 patients were
treated by complete vaporization. The TmFL was used in
noncontact mode with a power setting of 8.1  3.5 W and
4.7  1.4 minutes laser-on time.
Eighty-two bulky lesions in 72 patients were treated by
deep tissue destruction followed by immediate mechanical
resection. The activated laser fiber was inserted into the
exophytic intraluminal tissue as tangentially to the airway
wall as possible with a power setting of 8.6  2.7 W and
9.2  8.0 minutes laser-on time. By covering the whole
volume of an exophytic lesion via multiple entry points
on the surface, lesions were coagulated and carbonized.FIGURE 2. Introduction of the laser fiber and the flexible bronchoscope
through the rigid instrument.
The Journal of Thoracic and CarThe destructed tissue was then removed mechanically in
the same procedure. Using this technique, the silica fiber
tip comes in direct contact with the heated tissue, resultingtotal>187 and>100%)
Location n %
Upper third of trachea 33 17.6
Middle third of trachea 15 8.0
Lower third of trachea 25 13.4
Right main stem bronchus 67 35.8
Right upper lobe bronchus 35 18.7
Intermediate bronchus 43 23.0
Middle lobe bronchus 18 9.6
Right lower lobe bronchus 17 9.1
Left main stem bronchus 65 34.8
Left upper lobe bronchus 25 13.4
Left lower lobe bronchus 26 13.9
diovascular Surgery c Volume 147, Number 6 1829
FIGURE 3. Degree of airway stenosis before and after the procedure,
assessed according to a recently proposed scale.27
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emission, requiring frequent renewing and cleaving.
Nevertheless, this laser energy application technique allows
rapid debulking.
In 30 cases (18 patients) with a stricture or hourglass-
shaped stenosis, accurate incision of the lesion was
achieved by moving the activated laser fiber repeatedly
across the tissue either in contact or at 2 mm distance
(Video 1). By mechanical dilation of the incised lesion, im-
mediate airway patency was achieved in all cases. As a
result of recurrence of the lesion, the procedure had to be
repeated once in 2 patients, twice in 2 patients, and 6 times
in 1 patient (power setting, 7.5  2.5 W; laser-on time, 3.6
 5.5 minutes).
In 28 cases (26 patients), TmFL was used to achieve
hemostasis. Spontaneous tumor bleeding occurred in 18
cases, whereas 10 episodes of bleeding occurred after
endobronchial measures (after biopsy n ¼ 2, after
mechanical resection n ¼ 8). Light application was
performed in noncontact mode to achieve superficial
coagulation of a large surface area at a power setting of
8.7  2.2 W and laser-on time of 3.8  3.5 min. In most
cases, rapid and sustained hemostasis was achieved. In 3
cases, however, laser application had to be combined with
tamponade and/or stenting to achieve complete hemostasis.
Lesions Within Airway Stents
In 57 cases (31 patients), the TmFL was applied within
preexisting airway stents originally placed in 15 patients
for benign lesions and in 16 patients for malignant lesions.
To minimize the risk of ignition, the power setting was
restricted to 5 W in these situations.29
In 10 cases, partially covered nitinol stents (Ultraflex
[Boston Scientific, Natick, Mass], n ¼ 4; Leufen ECO-
Stent [Micro-Tech, Nanjing, China], n ¼ 6) were removed
after laser resection of severe tissue overgrowth (granula-
tion tissue, n ¼ 6; tumor tissue, n ¼ 4). The stents were1830 The Journal of Thoracic and Cardiovascular Suruncovered by superficial ablation of overgrowing tissue
without deep damage to the airway wall. Direct contact of
the laser probe with nitinol struts produced flashing phe-
nomena but no fire or emission of sparks was observed.
Some struts were cut accidently by direct laser energy appli-
cation, but the stents remained adequately intact to be ex-
tracted with rigid forceps. The location of the stents that
were removed was trachea (n¼ 2), bifurcation (n¼ 1), right
main stem bronchus (n ¼ 3), left main stem bronchus
(n ¼ 2), and intermediate bronchus (n ¼ 2). In 5 cases, a
new stent was placed during the same procedure using a
fully covered metallic stent (n ¼ 4) or silicone stent
(n ¼ 1). Attempts to remove a metallic stent failed in 2
cases. Overall, the laser-on time for tissue removal from
tissue-covered stents was 13.2  11.8 minutes.
In 47 cases, preexisting stents (silicone stents, n ¼ 13;
metallic stents, n ¼ 34) remained intact and were retained
after laser-assisted ablation of in-stent tissue (Video 2).
Laser-assisted tissue removal was performed close to the
stent wall without relevant damage to the stent material.
The laser-on time for these procedures was 5.1  5.5
minutes.Complications
Bleeding from tumor tissue was induced by laser
treatment in 5.8% (n ¼ 11 of 187). During these
procedures, the laser fiber was introduced into exophytic
malignant tissue to achieve deep tissue destruction. Five
bleeding episodes were minor, requiring no specific action.
A further 5 episodes were moderate necessitating temporary
tamponade of the bleeding airway with swabs. In 1 case of a
bleeding carcinoid tumor of the right upper lobe, a covered
metal stent was placed over the lobar orifice to achieve
permanent hemostasis. No other prespecified or unexpected
complications were observed in this study.DISCUSSION
Endobronchial laser treatment is well established in
interventional bronchology. Although the Nd:YAG laser
is most commonly used, we report our results of endo-
bronchial laser therapy using a TmFL. Because the TmFL
wavelength of 1940 nm shows high absorption in tissue
water, a well-defined laser effect with a high degree of
accuracy can be achieved. Laser-induced coagulation
effects ranged within 1 to 2 mm instead of uncontrollable
deep tissue coagulation.
Summarizing the clinical experience of this study, the
following principles of endobronchial treatment with the
TmFL were established:
1. Vaporization: small lesions can be completely vaporized
(n ¼ 81).
2. Deep tissue destruction followed by mechanical
resection: theoretically, the superficial action of thegery c June 2014
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disadvantageous for the treatment of bulky lesions. But
the experience of this case series shows that the activated
laser fiber can be introduced into exophytic intraluminal
tissue to achieve deep tissue destruction followed by
mechanical removal of the coagulated and carbonized
tissue (n ¼ 82). As a result of the well-circumscribed
action of the laser energy, the depth of tissue destruction
virtually corresponds to the depth of the fiber tip and thus
can be well controlled by the operator. Using this
beneficial technique, however, 2 potential risk factors
should be kept in mind. The introduction of the fiber
into tissue can induce bleeding by direct mechanical
injury of vessels and there is a risk of perforating the
airway wall if airway anatomy is not respected.
3. Cutting/incision: in 21 cases with a stricture, exact radial
incisions were made by moving the activated laser fiber
repeatedly across the tissue either in contact or at 2 mm
distance, followed by mechanical dilation. The cutting
effect of the TmFL in strictures is comparable with
the effect of electrocautery using a monopolar electro-
surgical knife.
4. Hemostasis: the light energy of the TmFL was highly
effective for hemostasis. As a result of high absorption
in water, blood and other fluids on the tissue
surface were rapidly vaporized followed by superficial
coagulation of the bleeding tissue in noncontact mode
(n ¼ 28).
5. Removal of stent-associated tissue: the TmFL was safely
used for ablation of granulation tissue in airway stents
when restricted to a power setting of 5 W (n ¼ 57).
Using these handling principles, there was no evidence of
a difference in the efficiency of tissue destruction in relation
to the histology of the treated endobronchial lesions.
Endobronchial therapy by means of the TmFL was safe
when adhering to restrictions in power setting (<20 W,
5 W with preexisting airway stents) and the fraction of
inspired oxygen (<40%), which is further supported by
the relatively low-energy application of less than 20 W
using 1940 nm compared with less than 45 W using the
Nd:YAG laser.3 Furthermore, the TmFL enabled fast tissue
ablation with few bleeding events and without any
observation of the so-called popcorn- effect. The experience
of this study shows that sparks can be arise when high
energy levels (>20W) are applied to desiccated and charred
tissue. The emission of sparks from the tissue should be
regarded as a sign of imminent laser-induced fire, which
should lead to immediate deactivation of the laser by the
treating physician.
All interventions in this study were performed
under general anesthesia using combined rigid and
flexible bronchoscopy. This contributes to the safety of
the procedure. General anesthesia guarantees the bestThe Journal of Thoracic and Carconditions for complex interventions. The rigid broncho-
scope enables ventilation and access to the airways
and allows the use of rigid instruments for rapid
debridement of tissue destroyed by the laser. It is
indispensable for the removal of airway stents. The flexible
bronchoscope ensures accurate targeting of the laser
fiber and increases the peripheral range of laser therapy.
The results of this study cannot be generalized to a pure
flexible bronchoscopy technique. Many of the complex
procedures described in this study with a procedure time
of up to 200 minutes could not have been performed with
the same safety, accuracy, and efficacy using a flexible
system alone.
The most remarkable aspect of this case series is the use
of the TmFL for tissue removal within preexisting airway
stents. Resection in close proximity to airway stents using
the Nd:YAG laser carries the risk of damaging the stent,
including ignition.30,31 Using the TmFL with the power
restricted to 5 W and applying the laser energy tangential
to the stent wall, tissue overgrowing stents can be safely
resected without obvious damage to the stents and the
adjacent airway wall.
In benign airway stenosis, the use of metallic stents has
been discouraged because of the long-term risks including
incorporation in severe granulation tissue. Removal of these
stents can be hazardous.32,33 As a result of its superficial
effects, the TmFL seems to be an excellent tool for the
removal of metallic airway stents. In this study, the TmFL
was successfully used for severe stent overgrowth.
However, this observation needs to be supported by
ex vivo investigations29 and comparison trials with the
Nd:YAG laser.
In this study, TmFL laser resection was frequently
combined with other endobronchial treatments, indicating
that laser bronchoscopy is most effective as part of a
multimodality endobronchial approach. The high number
of stents placed in this study is explained by the high
percentage of combined stenosis of exophytic tissue and
extrinsic compression, for which laser-assisted resection
was followed by stenting to achieve full patency of the
airway.34 Otherwise, laser light application was frequently
used for hemostasis of bleeding after cryoextraction of
exophytic tumor tissue.
Several limitations of this study should be addressed.
First, there are no long-term follow-up or mortality data
for this patient cohort. Second, a heterogeneous patient
group with a large variety of benign and malignant lesions
was included in this trial. Third, the results of the
procedures were assessed visually and subjectively by the
investigators. Objective means, such as radiographic
assessment of bronchial diameter, were not used. Fourth,
the study does include comparison with the Nd:YAG laser.
Definitive conclusions regarding the superiority of the
TmFL cannot be drawn.diovascular Surgery c Volume 147, Number 6 1831
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with endobronchial Nd:YAG laser therapy, a perspective on
this issue can be given. The TmFL seems to have several
promising advantages: higher absorption in tissue renders
higher efficiency, accelerating tissue destruction and
improving safety using lower power settings. The precise
effect allows for better targeting of pathologic tissue
conserving healthy deeper layers of the airway wall, which
is especially important in delicate situations like the
removal of ingrown stents. The results of this study show
that, particularly with laser treatment of in-stent tissue,
the TmFL enables interventions that would not be possible
with an Nd:YAG laser.
Further trials covering these limitations, especially
addressing the long-term effects in distinct patient
populations and comparing TmFL with Nd:YAG laser
treatment, should be undertaken to evaluate the potential
of TmFL to improve endobronchial laser therapy.
CONCLUSIONS
Endobronchial therapy with the TmFL emitting at 1940
nm looks promising as a safe and versatile treatment
modality for airway stenoses and stent obstructions caused
by tissue ingrowth, with potential advantages compared
with the Nd:YAG laser. Comparison studies are warranted.
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